Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02682667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02682667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
April 11, 2016
Completion date
December 1, 2032
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin disease, leukemia-lymphoma, adult t-cell, lymphoma, non-hodgkin, multiple myeloma, non-small cell lung cancer